drugset
Drugs / Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells
last change Apr 2014 re-read 3 minutes ago

Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells

Developed for
granulomatous disease, chronic, X-linked
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

today NCT00394316 · Ph 0
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT00394316 Oct 2006 → Apr 2014 granulomatous disease, chronic, X-linked National Institute of Allergy and Infectious Diseases (NIAID) Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT00394316 ↗
Action Restore “The cells are then able to produce the normal protein.” NCT00394316 ↗